Lupin gets USFDA nod to market generic HIV drug

The company has received approval from the United States Food and Drug Administration (USFDA) to market its Emtricitabine and Tenofovir Disoproxil Fumarate tablets, 200 mg/300 mg, Lupin said in a regulatory filing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3w1SSH4
via IFTTT